Skip to main content
Lupin Ltd logo

Lupin Ltd — Investor Relations & Filings

Ticker · LUPIN ISIN · INE326A01037 LEI · 335800HHXTESDEE2FC65 BSE.NS Manufacturing
Open in API
Filings indexed 3,178 across all filing types
Latest filing 2024-03-22 Capital/Financing Update
Country IN India
Listing BSE.NS LUPIN

About Lupin Ltd

https://www.lupin.com/

Lupin Ltd is a global pharmaceutical organization specializing in the development, manufacturing, and marketing of a comprehensive range of generic and branded formulations, biotechnology products, and active pharmaceutical ingredients. The company holds a significant market position in therapeutic segments such as cardiovascular, diabetology, asthma, pediatrics, gastrointestinal, anti-infectives, and non-steroidal anti-inflammatory drugs. It is notably recognized for its leadership in the anti-tuberculosis medication sector. With a strong emphasis on research and development, Lupin focuses on complex generics, specialty medicines, and biosimilars. The company operates advanced manufacturing facilities and maintains a substantial commercial presence across major global markets, including North America, Europe, and the Asia-Pacific region, delivering affordable and high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
The Company plans to carve out, its trade generics business in India, as a going concern, on a slump sale basis, to Lupin Life Sciences Limited, wholly owned subsidiary of the Company.
Capital/Financing Update Classification · 95% confidence The document is a formal disclosure addressed to stock exchanges (BSE and NSE) pursuant to Regulation 30 of SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. It details a planned business transaction: the carve-out and slump sale of the company's trade generics business in India to its wholly owned subsidiary. The document includes specifics such as turnover, net worth, expected completion date, consideration, related party status, and rationale for the transaction. It is an announcement of a significant corporate transaction rather than a financial report, earnings release, or management discussion. There is no financial statement or detailed financial analysis presented, nor is it a report or presentation. The content fits the category of Capital/Financing Update (CAP) as it relates to a material transaction affecting the company's business structure and capital allocation.
2024-03-22 English
Updates
Regulatory Filings Classification · 95% confidence The document is a disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which relates to an announcement of a significant corporate event. It details the Board of Directors' approval of a business transfer agreement to carve out the trade generics business to a wholly owned subsidiary. The document includes specifics about the transaction, such as turnover, consideration, related party status, and rationale. It is an announcement of a corporate restructuring transaction rather than a full financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial analysis but is a regulatory announcement about a material event. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements that do not fit other specific categories.
2024-03-22 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) informing about the closure of the trading window for designated persons due to insider trading regulations. It references SEBI regulations and the timing of the trading window closure around the announcement of financial results for FY 2023-24. The content is a regulatory announcement related to insider trading compliance and trading restrictions, not a financial report, earnings release, or any detailed financial data. The document length is short (2015 characters) and it serves as a notification rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-03-22 English
Intimation regarding trading window closure.
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the closure of the trading window for designated persons due to insider trading regulations, specifically referencing SEBI regulations. It does not contain any financial data, results, or detailed report content. The document length is only 2015 characters, which is quite short and consistent with an announcement rather than a full report. It is notifying about a trading window closure period related to upcoming financial results but does not include the results themselves or any financial statements. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance-related notices that do not fit other categories.
2024-03-22 English
Updates
Regulatory Filings Classification · 95% confidence The document is a formal disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about an order received from a tax authority imposing tax, interest, and penalty. The document includes details of the order, the nature of the alleged violation, and the company's response. It is a regulatory announcement about a legal/tax matter rather than a financial report, earnings release, or management discussion. The document length is 4368 characters, which is relatively short and primarily serves as a notification. There is no financial statement or detailed financial analysis present. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance disclosures that do not fit other specific categories.
2024-03-21 English
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Regulatory Filings Classification · 95% confidence The document is a disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about an order received from a tax authority imposing tax, interest, and penalty. The document is relatively short (4404 characters) and serves as an announcement of a regulatory event rather than a detailed report. It does not contain financial statements or detailed financial analysis. The content fits the description of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not fit into other specific categories like Audit Report, Annual Report, or Legal Proceedings Report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2024-03-21 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.